Sarcoidosis Market and Epidemiology Report 2022-2032: Key Players, Developments and Opportunities
June 28, 2022 06:33 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Sarcoidosis - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. Report Highlights ...
Middle East Respiratory Syndrome Coronavirus S Protein Drugs Report 2022: Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
June 13, 2022 04:43 ET
|
Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Middle East Respiratory Syndrome coronavirus S Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...
Alpha-1 Antitrypsin Deficiency Market Research Report 2022: Unmet Needs and Opportunities, Treatment Options, Pipeline Assessment, R&D Strategies, Outlook
June 10, 2022 07:48 ET
|
Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical...
APAC Idiopathic Pulmonary Fibrosis Market to 2027 - Size, Share & Industry Trends Analysis Report
May 19, 2022 05:03 ET
|
Research and Markets
Dublin, May 19, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
World RSV Vaccine and Antibody Pipeline Market Report 2022 - Growing Instances of RSV Among Infants
May 13, 2022 07:23 ET
|
Research and Markets
Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus Vaccine And Antibody Pipeline Market: Analysis By End User, By Type, By Region, Size and Trends with Impact of...
The Worldwide Asthma and COPD Drugs Industry is Expected to Reach $52 Billion by 2030
May 04, 2022 08:03 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asthma and COPD Drugs Market by Diseases and Medication Class (Combination Drugs, Inhaled Corticosteroids, Short Acting Beta Agonists, Long Acting Beta...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Expected to Reach $4.7 Billion by 2027
April 25, 2022 07:08 ET
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Projected to Reach $6 Billion by 2030
March 31, 2022 06:13 ET
|
Research and Markets
Dublin, March 31, 2022 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has...
Global Respiratory Partnering Directory/Report 2021: Access to Deals Signed Since 2010
March 18, 2022 08:53 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology Report 2022-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan
March 09, 2022 06:18 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's...